0
0
2/17/26 at 12:05pm
Organization
STAT
Author
Adam Feuerstein
40 words
0
Comments
Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question.
You are the first to view
https://www.statnews.com/2026/02/17/ocular-therapeutix-axpaxli-wet-amd-treatment-compared-to-eylea-regeneron/
Create an account
or login to join the discussion